| David J Leicht, PHD | |
|
444 N Westhill Blvd, Appleton, WI 54914-5715 | |
| (920) 750-7000 | |
| (920) 364-2451 |
| Full Name | David J Leicht |
|---|---|
| Gender | Male |
| Speciality | Clinical Psychologist |
| Experience | 36 Years |
| Location | 444 N Westhill Blvd, Appleton, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417941071 | NPI | - | NPPES |
| 39078500 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | 1357 (Wisconsin) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bellin Psychiatric Center Inc | 4486551058 | 60 |
News Archive
PTC Therapeutics, Inc. today announced that final analyses of Phase 2b efficacy data suggest the investigational new drug ataluren slowed the loss of walking ability in patients with nonsense mutation dystrophinopathy, a disease continuum comprising Duchenne and Becker muscular dystrophy (nmDBMD). These data were presented at the International Congress of the World Muscle Society in Kumamoto, Japan and will be the basis of interactions with the U.S. Food and Drug Administration (FDA) and national regulatory authorities in Europe in the fourth quarter of 2010.
Advancing age is a major risk factor for Alzheimer's disease and is associated with build- up of the peptide amyloid β in the brain. New research published in BioMed Central's open access journal Fluids and Barriers of the CNS shows that removal of amyloid β from the brain depends on vitamin D and also on an age-related alteration in the production of transporter proteins which move amyloid β in and out of the brain.
New research led by SUNY Downstate Medical Center shows that mice devoid of PKMzeta, a molecule previously identified by SUNY Downstate scientists as essential to memory formation and storage, recruit a closely related molecule, PKCiota/lambda, to make up for the missing PKMzeta.
Acute kidney injury (AKI) is sudden kidney failure or damage lasting from a few hours to several days. During this time, the kidney's ability to maintain a proper balance of bodily fluids is compromised and causes a buildup of waste products in the blood.
Mylan Inc. today announced its financial results for the three months ended March 31, 2010.
› Verified 9 days ago
| Entity Name | Bellin Psychiatric Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952554800 PECOS PAC ID: 4486551058 Enrollment ID: O20031212000884 |
News Archive
PTC Therapeutics, Inc. today announced that final analyses of Phase 2b efficacy data suggest the investigational new drug ataluren slowed the loss of walking ability in patients with nonsense mutation dystrophinopathy, a disease continuum comprising Duchenne and Becker muscular dystrophy (nmDBMD). These data were presented at the International Congress of the World Muscle Society in Kumamoto, Japan and will be the basis of interactions with the U.S. Food and Drug Administration (FDA) and national regulatory authorities in Europe in the fourth quarter of 2010.
Advancing age is a major risk factor for Alzheimer's disease and is associated with build- up of the peptide amyloid β in the brain. New research published in BioMed Central's open access journal Fluids and Barriers of the CNS shows that removal of amyloid β from the brain depends on vitamin D and also on an age-related alteration in the production of transporter proteins which move amyloid β in and out of the brain.
New research led by SUNY Downstate Medical Center shows that mice devoid of PKMzeta, a molecule previously identified by SUNY Downstate scientists as essential to memory formation and storage, recruit a closely related molecule, PKCiota/lambda, to make up for the missing PKMzeta.
Acute kidney injury (AKI) is sudden kidney failure or damage lasting from a few hours to several days. During this time, the kidney's ability to maintain a proper balance of bodily fluids is compromised and causes a buildup of waste products in the blood.
Mylan Inc. today announced its financial results for the three months ended March 31, 2010.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David J Leicht, PHD 444 N Westhill Blvd, Appleton, WI 54914-5715 Ph: (920) 750-7000 | David J Leicht, PHD 444 N Westhill Blvd, Appleton, WI 54914-5715 Ph: (920) 750-7000 |
News Archive
PTC Therapeutics, Inc. today announced that final analyses of Phase 2b efficacy data suggest the investigational new drug ataluren slowed the loss of walking ability in patients with nonsense mutation dystrophinopathy, a disease continuum comprising Duchenne and Becker muscular dystrophy (nmDBMD). These data were presented at the International Congress of the World Muscle Society in Kumamoto, Japan and will be the basis of interactions with the U.S. Food and Drug Administration (FDA) and national regulatory authorities in Europe in the fourth quarter of 2010.
Advancing age is a major risk factor for Alzheimer's disease and is associated with build- up of the peptide amyloid β in the brain. New research published in BioMed Central's open access journal Fluids and Barriers of the CNS shows that removal of amyloid β from the brain depends on vitamin D and also on an age-related alteration in the production of transporter proteins which move amyloid β in and out of the brain.
New research led by SUNY Downstate Medical Center shows that mice devoid of PKMzeta, a molecule previously identified by SUNY Downstate scientists as essential to memory formation and storage, recruit a closely related molecule, PKCiota/lambda, to make up for the missing PKMzeta.
Acute kidney injury (AKI) is sudden kidney failure or damage lasting from a few hours to several days. During this time, the kidney's ability to maintain a proper balance of bodily fluids is compromised and causes a buildup of waste products in the blood.
Mylan Inc. today announced its financial results for the three months ended March 31, 2010.
› Verified 9 days ago
Dr. Mindee Juve, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 10 Tri Park Way, Appleton, WI 54914 Phone: 920-831-0070 | |
Ms. Sharon L Gray, PSYCHOLOGIST Psychologist Medicare: Not Enrolled in Medicare Practice Location: 477 S Nicolet Rd, Appleton, WI 54914 Phone: 920-882-6610 Fax: 920-882-6611 | |
Kathleen Anne Clarke, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1506 S Oneida St, Appleton, WI 54915 Phone: 920-738-2681 | |
Dr. Brandon B Hayes, LP Psychologist Medicare: Accepting Medicare Assignments Practice Location: 4351 W College Ave Ste 410, Appleton, WI 54914 Phone: 800-438-1772 Fax: 262-345-5562 | |
Dr. Michael Marcy, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: Va Outpatient Clinic, Appleton, WI 54914 Phone: 920-831-7900 | |
Kristjana K Rahn, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1309 S Oneida St, Appleton, WI 54915 Phone: 920-903-8841 | |
Martin J Haanstad, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1531 S Madison St, Appleton, WI 54915 Phone: 920-730-4411 |